Ward 13 Alderman Dianne Colley-Urquart, who’s announced her intention to run for the Tory nomination in Calgary-Glenmore, has waded into the debate about the future of Calgary’s only laser prostate surgery machine. Colley-Urquart says she did some weekend door-knocking and was “blind-sided” over the matter from angry residents. Colley-Urquart says the city needs the machine and the province …
Archive for May, 2009
SNHMC Hosts American Cancer Society Man to Man Prostate Cancer Sup: J
For Immediate Release Contact: Judith Bennett Media Relations … – Judith.Bennett@snhmc.org
OncoGenex Prostate Drug Extends Survival
A phase II trial shows OncoGenex’s OGX-011 extended the survival of patients with advanced prostate cancer by almost seven months.
Gene Test Helps Detect Prostate Cancer
SUNDAY, May 31 (HealthDay News) — A new blood test greatly reduces false-positive results in prostate cancer screenings and, when used in combination with a prostate-specific antigen (PSA) test, could prevent many unnecessary biopsies, U.S. researchers say.
Running to Reclaim Your Body
After slogging through radiation and hormone therapy to treat his prostate cancer, Dana Jennings has taken up running again, with his sights set on running the New York Marathon in the fall.
Study: OncoGenex Prostate Drug Extends Survival
A phase II trial shows OncoGenex’s OGX-011 extended the survival of patients with advanced prostate cancer by almost seven months.
Group's seminar on prostate awareness
THE Association for Prostate Awareness will be running seminars on prostate cancer at All Saints Parish Church, Hampton Road, Forest Gate during the summer. The cancer is the second most common killer of men in the UK, with African Caribbean men three times more likely than white men to contract it.
Low oxygen level prostate tumors often recurrent
Hypoxia, or reduced oxygen levels, in prostate tumors significantly predicts a poor long-term biochemical outcome, regardless of other prognostic factors, such as tumor stage or type, according to results of a study presented at the American Society of Clinical Oncology’s annual meeting in Orlando.
False-Positives In Prostate Cancer Screening Greatly Reduced By New Blood Test
A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, painful, and costly prostate biopsies annually, according to a study led by researchers at Dana-Farber Cancer Institute.
Duke: Restricting carbohydrates may slow prostate tumors
DURHAM, N.C. — Restricting carbohydrates, regardless of weight loss, appears to slow the growth of prostate tumors, according to an animal study being published this week by researchers in the Duke Prostate Center.